Engaged in the application of proteomics research to clinical diagnosis.
Location: China, Shanghai
Employees: 201-500
Founded date: 2018
Investors 1
| Date | Name | Website |
| - | CDBI Partn... | cd-pe.com |
Mentions in press and media 2
| Date | Title | Description |
| 07.08.2026 | HuidaGene Hid Boy’s Gene Therapy Death for 12 Months: China Trial System Failed | By Devin Culbertson Published: Aug 07 2026, 8:53 AM EDT Share on Facebook Share on Twitter Share on LinkedIn Share on Reddit Share on Flipboard |
| 29.05.2024 | HuidaGene and Synthego Announce Licensing Agreement on Next-Generation Gene Editing Enzyme, hfCas12Max | SHANGHAI and REDWOOD CITY, Calif. , May 29, 2024 /PRNewswire/ -- HuidaGene Therapeutics ("HuidaGene"), a global clinical-stage biotechnology company focused on advancing CRISPR-based genomic medicines, and Synthego Corporation (&q... |